Sanofi-Aventis Earns $38 Million for Role in Blowing Whistle on Maker of EpiPens
- posted: Oct. 19, 2017
- Whistleblower Litigation
Sanofi-Aventis, a large pharmaceutical company, was awarded $38.7 million for its role in bringing a $465 million False Claims Act case against Mylan. The company settled amid allegations that it Read More